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EDITORS’ INTRODUCTIONTrans-Atlantic Debate: Should Young Patients with Good Risk Factors be
Treated with EVAR?As endovascular abdominal aortic aneurysm repair has
become increasingly prominent in our vascular surgery prac-
tices, the discussion regarding long term durability continues.
The initial randomized trials that enrolled patients almost 10
years ago revealed a short-term survival advantage with
endovascular repair (EVAR) at the expense of a higher re-
intervention rate and loss of that initial survival advantage
in the longer term. Continuing and healthy debate over the
practical importance of these ﬁndings has resulted in some-
what differing practice patterns on either side of the Atlantic.
This debate explores the issues surroundingwhether younger,
good risk patients with a long life expectancy should be
treated with endovascular repair (EVAR).1078-5884/$ e see front matter
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